TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9160851

Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarettes (0.1 mg per puff)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray (0.5 mg nicotine per spray)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vapor inhaler (estimated 0.013 mg nicotine per inhalation)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (0 puffs, sprays, or inhalations)
Number of subjects: 12
Study: 8226172

Group type: EXPERIMENTAL
Intervention: Radiation and simultaneous daily cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisplatin containing combination regimens with thoracic radiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thoracic radiation therapy with or without single agent cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative radiation and concurrent cisplatin containing combination therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation therapy and surgery
Number of subjects: 0
Study: 3780826

Group type: EXPERIMENTAL
Intervention: SUR2647 combination (2 g paracetamol X 2 on the day of operation, 1 g paracetamol X 2 on the following two days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SUR2647 combination
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo caplets
Number of subjects: 30
Study: 29383893

Group type: EXPERIMENTAL
Intervention: Tiaoshen Kaiyu acupuncture plus standard treatment and psychological intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard treatment plus psychological intervention (control group)
Number of subjects: 94
Study: 27132819

Group type: EXPERIMENTAL
Intervention: MFGM containing beverage consumed for six weeks
Number of subjects: 38
Study: 24879445

Group type: EXPERIMENTAL
Intervention: Empowerment-inspired intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 22700826

Group type: EXPERIMENTAL
Intervention: CMS nonpayment policy for hospital-acquired CAUTI
Number of subjects: 2362742

Group type: EXPERIMENTAL
Intervention: Fluoroquinolone antimicrobial use
Number of subjects: 2362742
Study: 20089562

Group type: EXPERIMENTAL
Intervention: Epirubicin and cyclophosphamide (EC)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Epirubicin and docetaxel (ED)
Number of subjects: 240
Study: 17943623

Group type: EXPERIMENTAL
Intervention: Irremovable total‐contact casts (TCC)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Custom‐made temporary footwear (CTF)
Number of subjects: 43
Study: 15853099

Group type: EXPERIMENTAL
Intervention: Whitestrips (over-the-counter technique; one cycle=30 minutes)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Opalescence PF 10% (at-home bleaching technique; one cycle=8 hours)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Opalescence Xtra Boost (in-office bleaching technique; one cycle=15 minutes)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 39
Study: 12356153

Group type: EXPERIMENTAL
Intervention: CLOSED-RCT
Number of subjects: 48

Group type: COMPARATOR
Intervention: OPEN-RCT
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CLOSED-nonRCT
Number of subjects: 48

Group type: COMPARATOR
Intervention: OPEN-nonRCT
Number of subjects: 48
Study: 10224721

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide bleaching system 1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide bleaching system 2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide bleaching system 3
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison among the three bleaching systems
Number of subjects: 24
Study: 8544547

Group type: EXPERIMENTAL
Intervention: Oral morphine (up to 120 mg daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Benztropine (active placebo, up to 1 mg twice daily)
Number of subjects: 46
Study: 1860151

Group type: EXPERIMENTAL
Intervention: Rice-based oral rehydration therapy (ORT)
Number of subjects: 68345

Group type: COMPARATOR
Intervention: Sugar-based oral rehydration therapy (ORT)
Number of subjects: 68345
Study: 6351594

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 40

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 40
Study: 30576555

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (60 mg/d)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg/d)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 27068885

Group type: EXPERIMENTAL
Intervention: NasoPore packing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-resorbable traditional impregnated gauze packing
Number of subjects: 50
Study: 26304476

Group type: EXPERIMENTAL
Intervention: Commitment-based behaviour change techniques (reminders, implementation intentions, public commitment) combined with information
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Coping planning with reminders and information (in phase 2)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Information-only control group
Number of subjects: 710
Study: 25112302

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (intravenous saline solution)
Number of subjects: 200
Study: 21208417

Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 2016

Group type: EXPERIMENTAL
Intervention: sertraline
Number of subjects: 2016

Group type: EXPERIMENTAL
Intervention: venlafaxine
Number of subjects: 2016

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 2016
Study: 19659492

Group type: EXPERIMENTAL
Intervention: CRS training for chest pain or dyspnoea
Number of subjects: 146
Study: 17365749

Group type: EXPERIMENTAL
Intervention: Expressive writing plus brief office intervention
Number of subjects: 196

Group type: COMPARATOR
Intervention: Brief office intervention
Number of subjects: 196
Study: 14715336

Group type: COMPARATOR
Intervention: Placebo-treated patients with metabolic syndrome in 4S
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo-treated patients with metabolic syndrome in AFCAPS/TexCAPS
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Low high-density lipoprotein levels
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: High triglycerides in 4S
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Elevated blood pressure and obesity in AFCAPS/TexCAPS
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Patients with metabolic syndrome
Number of subjects: 2
Study: 11285552

Group type: EXPERIMENTAL
Intervention: Immediate postoperative radiation therapy (RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed radiation therapy (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose radiation therapy (approximately 45-50 Gray (Gy))
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose radiation therapy (approximately 60-65 Gy)
Number of subjects: 0
Study: 9336558

Group type: EXPERIMENTAL
Intervention: Walking/running group
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cycling group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 31
Study: 8179231

Group type: EXPERIMENTAL
Intervention: 60 mg of terfenadine twice daily for 1 week
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo twice daily for 1 week
Number of subjects: 19
Study: 2885946

Group type: EXPERIMENTAL
Intervention: Hemodilution (graded venesection 250‐1000 ml during the first 2 days and dextran 40 infusions 500 ml daily for 5 days)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Hemodilution
Number of subjects: 373

Group type: COMPARATOR
Intervention: Control
Number of subjects: 373
Study: 30324496

Group type: EXPERIMENTAL
Intervention: Snapcare app (App group) in addition to a written prescription
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional treatment (Conventional group) with a written prescription
Number of subjects: 93
Study: 26896734

Group type: EXPERIMENTAL
Intervention: Terlipressin plus albumin
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo plus albumin
Number of subjects: 196
Study: 25437716

Group type: EXPERIMENTAL
Intervention: Transcervical intralesional vasopressin injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23289262

Group type: EXPERIMENTAL
Intervention: First trimester of pregnancy
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Second trimester of pregnancy
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Overall sexual satisfaction
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Frequency of sexual contacts
Number of subjects: 130
Study: 20334708

Group type: EXPERIMENTAL
Intervention: Pomegranate seed oil (PSO) 400 mg twice daily
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 18773990

Group type: EXPERIMENTAL
Intervention: Hormone therapy (E-Alone)
Number of subjects: 24532

Group type: EXPERIMENTAL
Intervention: Hormone therapy (E+P)
Number of subjects: 24532
Study: 15904514

Group type: EXPERIMENTAL
Intervention: Typhoid Vi polysaccharide vaccine
Number of subjects: 118588
Study: 11921698

Group type: EXPERIMENTAL
Intervention: Hormonal Replacement Therapy (HRT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 9895090

Group type: EXPERIMENTAL
Intervention: 0.2% enflurane with 80% N2O
Number of subjects: 14

Group type: COMPARATOR
Intervention: 0.2% enflurane without 80% N2O
Number of subjects: 14
Study: 7573074

Group type: EXPERIMENTAL
Intervention: Randomly assigned intensity of exposure (0.1-40 fibers/ml)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cumulative exposure
Number of subjects: 200
Study: 2099961

Group type: EXPERIMENTAL
Intervention: Combined intravenous and oral Pentoxifylline
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7007058

Group type: EXPERIMENTAL
Intervention: Methenamine hippurate (MH), 1 g three times daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, 1 g three times daily
Number of subjects: 0
Study: 30957284

Group type: EXPERIMENTAL
Intervention: Three-miRNA signature (miR130b, miR-18a, miR-223)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-miRNA signature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomograms integrating three-miRNA signature and clinicopathological risk factors
Number of subjects: 0
Study: 28066879

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg weekly dosing
Number of subjects: 0
Study: 26175533

Group type: EXPERIMENTAL
Intervention: Personalized site performance feedback intervention at 73 hospitals (n=33,886 patients)
Number of subjects: 71829

Group type: COMPARATOR
Intervention: Control group at 74 hospitals (n=37,943 patients)
Number of subjects: 71829

Group type: EXPERIMENTAL
Intervention: Individual achievement measures and quality measures
Number of subjects: 71829
Study: 23190780

Group type: EXPERIMENTAL
Intervention: PncCRM vaccine
Number of subjects: 2497

Group type: EXPERIMENTAL
Intervention: PncOMPC vaccine
Number of subjects: 2497

Group type: COMPARATOR
Intervention: Control group (hepatitis B vaccine)
Number of subjects: 2497
Study: 21104834

Group type: EXPERIMENTAL
Intervention: Fsoy (aglycone-rich fermented soybeans)
Number of subjects: 11
Study: 20017681

Group type: EXPERIMENTAL
Intervention: Personal FM systems used during the school day for 6 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no FM systems)
Number of subjects: 46
Study: 16061916

Group type: EXPERIMENTAL
Intervention: Sensitivity and specificity presentation format
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Likelihood ratio presentation format
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Graphical presentation format
Number of subjects: 183

Group type: COMPARATOR
Intervention: Sensitivity and specificity vs. likelihood ratio
Number of subjects: 183
Study: 12476605

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9924864

Group type: EXPERIMENTAL
Intervention: Intensive Early Intervention Program (EIP) with 4 prenatal classes and approximately 17 home visits by specially trained public health nurses.
Number of subjects: 121

Group type: COMPARATOR
Intervention: Traditional Public Health Nursing (TPHN) care with three home visits.
Number of subjects: 121
Study: 8950498

Group type: EXPERIMENTAL
Intervention: Inogatran (low molecular weight thrombin inhibitor)
Number of subjects: 37
Study: 2031078

Group type: EXPERIMENTAL
Intervention: Recombinant alpha 2b-interferon alone (6 weeks of placebo syrup followed by 16 weeks of recombinant alpha 2b-interferon, 5 x 10(6) u/m2 subcutaneously thrice weekly)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Recombinant alpha 2b-interferon with steroid priming (6 weeks of syrup prednisone followed by 16 weeks of recombinant alpha 2b-interferon)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (syrup vitamin B complex)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 7171405

Group type: EXPERIMENTAL
Intervention: Remler M2000
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hawksley sphygmomanometer
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sphygmolog
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Remler
Number of subjects: 58
Study: 31551223

Group type: EXPERIMENTAL
Intervention: Combined therapy of Zushima tablet and western medicine
Number of subjects: 170

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 170
Study: 28384523

Group type: EXPERIMENTAL
Intervention: Universal school-based intervention targeting resilience protective factors
Number of subjects: 3115

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3115
Study: 25554995

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 138
Study: 22546664

Group type: EXPERIMENTAL
Intervention: Discussion of personal concerns
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Discussion of relationship problems
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Greater attachment anxiety among women
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Greater attachment avoidance among women
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Greater attachment anxiety among men
Number of subjects: 34
Study: 21422390

Group type: EXPERIMENTAL
Intervention: MitraClip device implantation
Number of subjects: 50
Study: 19861394

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 0
Study: 18590256

Group type: EXPERIMENTAL
Intervention: Multiple point procedure
Number of subjects: 96

Group type: COMPARATOR
Intervention: Single point procedure
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Partial removal with drills without cooling
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Partial removal with water spray cooled drills
Number of subjects: 96
Study: 16091427

Group type: EXPERIMENTAL
Intervention: Patients enrolled in clinical trials (139 patients)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Non-study patients (135 patients)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Eligible patients who refused participation (28 patients)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Eligible patients not recruited despite meeting inclusion criteria (17 patients)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Non-study patients treated with chemotherapy
Number of subjects: 274
Study: 11815986

Group type: EXPERIMENTAL
Intervention: Sandwich chemotherapy (ifosfamide, etoposide, methotrexate, cisplatin, and cytosine arabinoside) followed by irradiation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Maintenance chemotherapy (lomustine, vincristine, and cisplatin) followed by irradiation
Number of subjects: 52
Study: 10881087

Group type: EXPERIMENTAL
Intervention: Mefloquine, 250 mg per day in a single dose for six days, repeated three weeks later.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Meglumine antimoniate (Glucantime), 20 mg/kg daily administered intravenously for 20 days.
Number of subjects: 20
Study: 8825113

Group type: EXPERIMENTAL
Intervention: Silver-coated catheters (SC)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard uncoated catheters (UC)
Number of subjects: 266
Study: 1799037

Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triiodinated agents
Number of subjects: 0
Study: 7278216

Group type: EXPERIMENTAL
Intervention: Cycling supine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cycling sitting
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alternate arm cranking standing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Walking on a treadmill
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Stepping on a bench
Number of subjects: 32
Study: 31120957

Group type: EXPERIMENTAL
Intervention: DAR-901
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 29925490

Group type: EXPERIMENTAL
Intervention: Bictegravir (50 mg), Emtricitabine (200 mg), Tenofovir alafenamide (25 mg)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Boosted protease inhibitor regimen
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Bictegravir group
Number of subjects: 578

Group type: COMPARATOR
Intervention: Boosted protease inhibitor group
Number of subjects: 578
Study: 26717109

Group type: EXPERIMENTAL
Intervention: Cytochrome c levels in septic patients
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cytochrome c levels at enrollment
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cytochrome c levels over time
Number of subjects: 77
Study: 24880443

Group type: EXPERIMENTAL
Intervention: Erythrina mulungu (500mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (500mg)
Number of subjects: 30
Study: 22213436

Group type: EXPERIMENTAL
Intervention: Exercise training (45%-55% VO(2peak), 30-60 minutes × 5 days/week; n = 12)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Observation (control; n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 18
Study: 20639802

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 1340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1340
Study: 17149725

Group type: EXPERIMENTAL
Intervention: NS 2330 (tesofensine) 0.25 mg
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: NS 2330 (tesofensine) 0.5 mg
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: NS 2330 (tesofensine) 1.0 mg
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study: 15607043

Group type: EXPERIMENTAL
Intervention: Oral Misoprostol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intravenous Oxytocin
Number of subjects: 16
Study: 12004636

Group type: EXPERIMENTAL
Intervention: Reminders (computer or chart)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Formal CME
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Computerized decision support systems/risk stratification
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Printed educational materials
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Academic detailing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous quality improvement projects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Disease management aids in patient charts
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study: 9803773

Group type: EXPERIMENTAL
Intervention: 240 mg of Ginkgo biloba extract (EGb)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 40 mg of tacrine
Number of subjects: 18
Study: 7652633

Group type: EXPERIMENTAL
Intervention: Meclofenamate (100 mg 3 times a day)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Diclofenac (50 mg 3 times a day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 2523646

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5, 5, 7.5, or 10 mg twice daily)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Atenolol (50 or 100 mg once daily)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Combination of isradipine and atenolol
Number of subjects: 152
Study: 1064902

Group type: EXPERIMENTAL
Intervention: Rapidly-disintegrating ferrous sulphate tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ferrous carbonate tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-release ferrous sulphate tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ferrous sulphate solution (reference)
Number of subjects: 0
Study: 31594195

Group type: EXPERIMENTAL
Intervention: Neurac technique
Number of subjects: 26

Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 26
Study: 29364027

Group type: EXPERIMENTAL
Intervention: Kinesiology Taping (KT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo Taping
Number of subjects: 30
Study: 26917439

Group type: EXPERIMENTAL
Intervention: 6-mm implants (test group)
Number of subjects: 94

Group type: COMPARATOR
Intervention: 10-mm implants (control group)
Number of subjects: 94
Study: 25122617

Group type: EXPERIMENTAL
Intervention: DVD-delivered home-based physical activity program
Number of subjects: 307

Group type: COMPARATOR
Intervention: Newspaper advertisements
Number of subjects: 307
Study: 22569050

Group type: EXPERIMENTAL
Intervention: Postoperative nasal spray regimens (specific regimens not detailed)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Preoperative SNOT scores
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Time post‐ESS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Presence of an adherence risk factor
Number of subjects: 60

Group type: COMPARATOR
Intervention: Age, gender, and nasal spray regimen
Number of subjects: 60
Study: 20439954

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment of malaria in infants (IPTi) with sulphadoxine‐pyrimethamine
Number of subjects: 600

Group type: COMPARATOR
Intervention: Comparison areas (Control)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: IPTi (per protocol analysis)
Number of subjects: 600
Study: 18561541

Group type: EXPERIMENTAL
Intervention: Sensitivity to vowel height changes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity to vowel backness changes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity to vowel roundedness changes
Number of subjects: 0